RHBC
MDT icon

R.H. Bluestein & Co’s Medtronic MDT Stock Holding History

R.H. Bluestein & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-295,947
Closed -$33.6M – 322
2019
Q4 		$33.6M Sell
295,947
-2,647
-0.9% -$290K 1.68% 27
2019
Q3 		$32.4M Buy
298,594
+3,487
+1% +$364K 1.82% 25
2019
Q2 		$28.7M Sell
295,107
-1,073
-0.4% -$98K 1.53% 29
2019
Q1 		$27M Buy
296,180
+21,697
+8% +$1.94M 1.47% 30
2018
Q4 		$25M Sell
274,483
-26,313
-9% -$2.46M 1.95% 24
2018
Q3 		$29.6M Buy
300,796
+22,692
+8% +$2.1M 1.43% 32
2018
Q2 		$23.8M Buy
278,104
+10,187
+4% +$851K 1.23% 37
2018
Q1 		$21.5M Buy
267,917
+18,707
+8% +$1.54M 1.18% 37
2017
Q4 		$20.1M Sell
249,210
-15,618
-6% -$1.25M 1.04% 41
2017
Q3 		$20.6M Sell
264,828
-53,403
-17% -$4.43M 1.13% 37
2017
Q2 		$28.2M Buy
318,231
+18,764
+6% +$1.58M 1.64% 29
2017
Q1 		$24.1M Buy
299,467
+37,670
+14% +$2.94M 1.45% 31
2016
Q4 		$18.6M Buy
261,797
+258,842
+8,759% +$20.3M 1.22% 35
2016
Q3 		$255K Buy
2,955
+480
+19% +$41.8K 0.02% 235
2016
Q2 		$215K Sell
2,475
-4,800
-66% -$388K 0.02% 259
2016
Q1 		$546K Buy
+7,275
New +$548K 0.04% 119
2015
Q2 		– Sell
-457,192
Closed -$35.7M – 342
2015
Q1 		$35.7M Sell
457,192
-13,384
-3% -$1.01M 2.15% 13
2014
Q4 		$34M Sell
470,576
-6,291
-1% -$437K 2.13% 15
2014
Q3 		$29.5M Buy
476,867
+11,760
+3% +$748K 1.85% 27
2014
Q2 		$29.7M Buy
465,107
+176,642
+61% +$10.7M 1.76% 26
2014
Q1 		$17.8M Buy
288,465
+274,265
+1,931% +$16M 1.17% 37
2013
Q4 		$815K Buy
+14,200
New +$805K 0.05% 138

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

R.H. Bluestein & Co's MDT Position: Q1 2020 in Review

R.H. Bluestein & Co sold out of Medtronic (MDT) in Q1 2020, closing a stake of 295,947 shares — an estimated $33.6M sold.

R.H. Bluestein & Co first reported a position in MDT in Q4 2013 and held it in 22 quarters. The position peaked at $35.7M in Q1 2015. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

  • R.H. Bluestein & Co reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
  • R.H. Bluestein & Co sold 295,947 Medtronic shares in Q1 2020, an estimated $33.6M.
  • R.H. Bluestein & Co first reported a position in Medtronic in Q4 2013 and held it in 22 quarters.
  • R.H. Bluestein & Co's Medtronic position peaked at $35.7M in Q1 2015.
  • 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on R.H. Bluestein & Co's 13F filing for Q1 2020, filed 12 May 2020.